KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Neogenomics (NEO) Long-Term Debt Repayments (2016 - 2019)

Historic Long-Term Debt Repayments for Neogenomics (NEO) over the last 11 years, with Q2 2019 value amounting to $3.2 million.

  • Neogenomics' Long-Term Debt Repayments rose 9771.6% to $3.2 million in Q2 2019 from the same period last year, while for Sep 2020 it was $3.2 million, marking a year-over-year decrease of 3594.0%. This contributed to the annual value of $201.2 million for FY2025, which is N/A changed from last year.
  • Latest data reveals that Neogenomics reported Long-Term Debt Repayments of $3.2 million as of Q2 2019, which was up 9771.6% from $1.8 million recorded in Q1 2019.
  • In the past 5 years, Neogenomics' Long-Term Debt Repayments registered a high of $32.4 million during Q3 2018, and its lowest value of -$58.9 million during Q4 2016.
  • In the last 5 years, Neogenomics' Long-Term Debt Repayments had a median value of $1.3 million in 2016 and averaged -$616764.7.
  • As far as peak fluctuations go, Neogenomics' Long-Term Debt Repayments plummeted by 499393.18% in 2016, and later surged by 226049.56% in 2018.
  • Quarter analysis of 5 years shows Neogenomics' Long-Term Debt Repayments stood at $1.2 million in 2015, then plummeted by 4993.93% to -$58.9 million in 2016, then surged by 92.99% to -$4.1 million in 2017, then soared by 884.92% to $32.4 million in 2018, then plummeted by 90.11% to $3.2 million in 2019.
  • Its Long-Term Debt Repayments was $3.2 million in Q2 2019, compared to $1.8 million in Q1 2019 and $32.4 million in Q3 2018.